Category: Press Release

Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune

Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company

Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate

Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders

Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate